A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. Post navigation Economic Toll of Los Angeles Fires Goes Far Beyond Destroyed HomesMister C.E.O. Goes to Washington for the Trump Inauguration
